Company Profile (AI Text)
Name: HepaTx Corporation
Canonical URL: https://wefunder.com/hepatx
Updated at: 2026-09-17T10:06:07Z

Tagline: The Development Of A Regenerative Cell Technology As An Alternative To Liver Transplants

Key claims:
- Total raised on Wefunder: 55000 | citation: https://wefunder.com/hepatx#claim-total-raised
- Total investors: 6 | citation: https://wefunder.com/hepatx#claim-total-investors

Verified facts:
- Total raised on Wefunder: 55000 | observed_at: 2026-09-17T10:06:07Z | expires_at: 2026-09-18T10:06:07Z
- Total investors: 6 | observed_at: 2026-09-17T10:06:07Z | expires_at: 2026-09-18T10:06:07Z

Computed metrics:
- total_amount_raised: 55000
- total_investors: 6
- team_size: 4
- featured_investor_count: 6
- faq_count: 0
- recent_post_count: 0

Quick facts:
- Raised $2.4M from Venture funds, including $500k from Greysky Venture Partners | citation: https://wefunder.com/hepatx#claim-fact-1
- Raised >$2M from Y Combinator Demo Day ($150k from YC, standard investment) | citation: https://wefunder.com/hepatx#claim-fact-2
- Collaboration and license deal with the Mayo Clinic to execute a first-in-human trial | citation: https://wefunder.com/hepatx#claim-fact-3
- $700k in grant funding received to date | citation: https://wefunder.com/hepatx#claim-fact-4
- Backed by prestigious venture funds and accelerators, including Y Combinator and StartX | citation: https://wefunder.com/hepatx#claim-fact-5
- Founded on breakthrough technology from Stanford University | citation: https://wefunder.com/hepatx#claim-fact-6